FLGR 242 (5mg)

FLGR 242 (5mg): Product Description

FLGR242 is a follistatin-related recombinant research material supplied for controlled laboratory studies involving activin, myostatin and other members of the transforming growth factor beta superfamily. Follistatin is a binding protein rather than a conventional short synthetic peptide, and its experimental characteristics depend on the precise recombinant construct and production process.

In-vitro research involving follistatin-related compounds may examine ligand binding, protein–protein interactions, receptor availability, cellular differentiation and signaling associated with myostatin or activin pathways. These models are useful for investigating complex regulatory networks in cultured cells and other controlled laboratory systems.

A single definitive molecular formula should not be assigned to FLGR242 without construct-specific information. Recombinant proteins can differ in amino-acid length, folding, glycosylation and other post-translational characteristics. For that reason, the batch Certificate of Analysis and manufacturer-provided sequence information should be treated as the controlling technical documentation.

Offers FLGR242 as two 5 mg vials. The Molecular Edge listing appears to refer to an individual 5 mg presentation.

Research Specifications

Material Type: Follistatin-related recombinant protein

Molecular Formula: Construct-dependent; no single formula published

Molecular Weight: Dependent on expressed construct and processing

Research Areas: Activin, myostatin and TGF‑β-superfamily signaling

Molecular Edge Presentation: 5 mg

Two 5 mg vials

For Research Use Only. Not for human or animal consumption. Not intended for diagnostic or therapeutic use.